Abstract
An open challenge in human genetics is to better understand the link between genotype variation and the various molecular, cellular, anatomical and physiological systems that it can affect. To address this challenge, we performed genotype-phenotype-systems analysis for accuracy in nine cognitive tasks from the Philadelphia Neurodevelopmental Cohort (3,319 individuals aged 8-21 years). We report a region of genome-wide significance within the 3’ end of the FBLN1 gene (p=4.6×10−8), associated with nonverbal reasoning, a heritable form of complex reasoning ability. Integration of published brain-specific ‘omic maps reveals that FBLN1 shows greatest expression in the fetal brain, is a marker of neural progenitor cells, is differentially expressed in schizophrenia and increases genetic risk for bipolar disorder. These findings suggest that nonverbal reasoning and FBLN1 variation warrant further investigation in studies of neurodevelopmental disorders and psychosis. Using genotype-pathway analysis, we identify pathways related to development and to autonomic nervous system dysfunction associated with working memory accuracy. Top-ranking pathway genes include those genetically associated with multiple diseases with working memory deficits, such as schizophrenia and Parkinson’s disease, and that are also markers for specific brain cell types. Our findings identify novel molecular players involved in specific cognitive tasks and link variants to genes, pathways, cell types, diseases and drugs. This work advances the “molecules-to-behaviour” view of cognition, and provides a framework for using systems-level organization of data for other biomedical domains.
Introduction
Human cognition is a highly heritable trait, yet identifying the specific genetic variants that influence it—and understanding the biological mechanisms through which they operate—remains a significant challenge. Traditional genetic studies often focus on "general intelligence" (the g-factor), which can obscure the distinct biological systems underlying specific cognitive domains such as spatial reasoning or working memory. This study addresses the "missing link" between genotype and phenotype by moving beyond simple gene-mapping to a multi-scale systems genomics framework. By integrating genome-wide association studies (GWAS) with functional 'omics data, the researchers aimed to trace how DNA variation ripples through molecular and cellular systems to manifest as differences in cognitive performance.
Methods and Data Integration
The study utilized a multi-scale approach to analyze data from the Philadelphia Neurodevelopmental Cohort (PNC), which includes cognitive and genetic data for 3,319 individuals aged 8–21. The methodology integrated several layers of biological information:
- Genotype-Phenotype Analysis: GWAS was performed on nine specific cognitive tasks using a mixed-effects linear model (MLMA) to account for polygenic contributions and population structure.
- Advanced SNP-to-Gene Mapping: To move beyond proximity-based mapping, the researchers employed Hi-C (3D chromatin interaction maps) and eQTL (expression quantitative trait loci) data from brain tissue. This allowed for the identification of genes that are physically distant in the linear DNA sequence but functionally linked in 3D space.
- Gene Set Enrichment Analysis (GSEA): This was used to identify biological pathways where multiple weak genetic signals aggregate into a significant theme, increasing statistical power.
- Functional Cross-Referencing: Findings were validated against single-cell RNA-seq data, developmental brain maps (BrainSpan), and drug-gene interaction databases (DGIdb).
Key Findings
FBLN1 and Nonverbal Reasoning
The most significant finding was a region of genome-wide significance ($p = 4.6 \times 10^{-8}$) within the 3’ end of the FBLN1 gene, specifically associated with nonverbal reasoning. Functional analysis revealed that FBLN1 expression peaks during prenatal development and is a marker for neural progenitor cells. Interestingly, FBLN1 is virtually absent in the adult brain, suggesting that variation in adult cognitive ability may be rooted in early neurodevelopmental "scaffolding."
Working Memory and Disease Overlap
Genotype-pathway analysis for working memory accuracy identified clusters of genes related to development and autonomic nervous system dysfunction. These pathways included "leading-edge" genes such as SNCA and LRRK2—well-known hallmarks of Parkinson’s disease. This suggests a shared genetic architecture between normative cognitive variation and major neuropsychiatric and neurodegenerative disorders.
Systems-Level Insights
The study identified 53 leading-edge genes for working memory pathways. Approximately 47% of these are known brain cell markers, and 36% have known drug interactions. This high degree of overlap demonstrates that the genes influencing normative cognition are also central to cellular identity and pharmacological targeting.
Discussion and Implications
This research advances a "molecules-to-behavior" view of human cognition. By demonstrating that FBLN1 variation is linked to both nonverbal reasoning and increased risk for bipolar disorder and schizophrenia, the study highlights the importance of investigating cognitive traits within the context of neurodevelopmental disorders. Furthermore, the discovery that working memory variation involves pathways shared with Parkinson’s disease provides a molecular basis for the cognitive deficits often seen in neurodegenerative conditions.
One notable methodological insight was the use of "binarization"—comparing the top and bottom thirds of performers. This approach strengthened the genetic signal compared to continuous scales, suggesting that extreme-phenotype sampling can be a powerful tool in behavioral genomics.
Limitations and Future Directions
While the study provides a robust framework, the sample size (~3,300) is modest compared to massive modern GWAS. The analysis was also limited to individuals of European ancestry to maintain stringency, necessitating future validation in more diverse global populations. Future work should involve testing these hypotheses in model systems, such as brain organoids, to determine if manipulating genes like FBLN1 directly alters the cellular circuits involved in complex reasoning. This systems-level framework offers a scalable model for exploring other complex biomedical domains beyond human cognition.
Summary updated